Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost adults starting Mounjaro begin on a 2.5mg weekly dose, rising through six possible strengths up to a maximum of 15mg, with each increase typically happening every four weeks. The schedule is set by your prescriber based on how well you tolerate the medicine, not on a fixed timetable. Mounjaro is a prescription-only medicine; a clinician decides the right dose for you after a full assessment. Here is what the licensed schedule looks like, and why each stage matters.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The 2.5mg starting dose exists for one reason: to let your digestive system adapt before the medicine starts doing its main job. Tirzepatide slows the rate at which food leaves the stomach and acts on two gut-hormone receptors (GIP and GLP-1) to reduce appetite and improve blood-sugar regulation. Starting at a low dose reduces the nausea and digestive discomfort that can otherwise hit hard in the first couple of weeks.
Think of it less as treatment and more as acclimatisation. Most people notice little in terms of appetite change at 2.5mg, and that is expected. The job of that first pen is purely adjustment. Once four weeks have passed and your prescriber is satisfied you are tolerating it well, the conversation about moving to 5mg begins.
The NHS medicines page for tirzepatide confirms this graduated approach, noting that dose increases happen no more frequently than every four weeks. Jumping ahead is not safer or faster — it is the kind of decision that requires the prescriber's eye on your full picture, not just impatience for results. If side effects at any stage feel unmanageable, the right move is to stay at the current dose for longer, again under prescriber guidance.
After the 2.5mg starter pen, the typical path runs: 5mg, then 7.5mg, then 10mg, then 12.5mg, and finally 15mg. That is five further increases, each separated by at least four weeks. In practice, many people spend longer at certain doses, particularly if they are tolerating a step well and losing weight steadily, or if a move upward causes significant side effects.
The prescriber weighs tolerability, weight response and any relevant health factors at every review. Reaching 15mg is not the goal in itself; the goal is the highest dose you can tolerate effectively. Some people find 10mg is where they settle. Others work up to 15mg over six months or more. There is no single right answer.
If you want a closer look at what the KwikPen itself delivers at each strength, our guide to Mounjaro pen doses covers how each pre-filled pen is set up. And for those who wonder how the injected volume translates across strengths, the dose in millilitres breakdown explains what you are actually injecting at each stage.
One practical note: each KwikPen delivers four weekly doses of the same strength. So a single pen covers one full month at that level. If you order by midday on a working day, it dispatches the same afternoon and arrives with DPD the next working morning, useful to know if you are due to move up a dose and want to time it without a gap.
No two people move through the Mounjaro schedule at exactly the same pace, and that is by design. Your prescriber looks at how you are tolerating the current dose, whether you are experiencing side effects that need more time to settle, how your weight is responding, and any relevant medical history or medicines that interact with the treatment.
The licensed maximum is 15mg once weekly. NICE's appraisal of tirzepatide (TA1026) notes that if someone has not achieved at least 5% weight loss after six months at their highest tolerated dose, continuing treatment should be reviewed. That review sits with the prescriber, it is not a decision the patient makes alone.
There is also the question of what happens if you miss a dose or need to pause treatment temporarily. The Patient Information Leaflet and your prescriber are the right sources for those scenarios; a content page cannot substitute for clinical advice on timing adjustments. Our clinical team reviews every consultation personally, and questions about pacing or pausing treatment belong in that conversation.
For context on how the range of doses compares across the full schedule, our Mounjaro dosage overview covers the broader picture, including the evidence behind each licensed strength.
The side effects people notice most are digestive: nausea, loose stools, constipation, indigestion, burping and sometimes vomiting. These are most noticeable after starting treatment or stepping up a dose, and for many people they ease within a week or two as the body adjusts. Fatigue, mild headache and dizziness are also reported, particularly early on.
More serious but uncommon reactions include symptoms of pancreatitis (severe stomach pain that radiates towards the back, sometimes with vomiting) which require urgent medical attention. If you suspect a serious reaction at any dose level, contact a healthcare professional promptly. You can also report any suspected side effect through the MHRA's Yellow Card scheme, which helps regulators monitor medicines in real-world use.
Side effects that return or worsen after a dose increase are a signal worth discussing with your prescriber before moving further. Staying at a lower dose for an extra month is a legitimate, clinician-guided option, not a failure. The maximum dose of Mounjaro page goes into more detail on when 15mg is appropriate and what the evidence says about higher-dose results.
If cost is something you are weighing as part of your decision, our Mounjaro price guide explains how private treatment is structured and what a transparent single price covers at each stage, and if you are also trying to make sense of what each strength means in practical terms, our guide to Mounjaro dosage in units breaks down exactly how each dose is measured.
Ready to find out which dose and approach would suit you? Check your eligibility with our prescribers, the consultation is free, takes a few minutes, and is reviewed by a real clinician the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.